Suppr超能文献

[牛肾上腺髓质嗜铬颗粒儿茶酚胺转运体的分子药理学]

[Molecular pharmacology of the catecholamine transporter of chromaffin granules from the bovine adrenal medulla].

作者信息

Henry J P, Scherman D, Roisin M P, Gasnier B, Isambert M F

出版信息

Biochimie. 1986 Mar;68(3):451-8. doi: 10.1016/s0300-9084(86)80012-8.

Abstract

Tetrabenazine (TBZ) and reserpine are two inhibitors of the catecholamine uptake system of the chromaffin granule membrane. They are structural analogs of the substrates dopamine and serotonin and they inhibit the monoamine transporter, which catalyzes a H+/neutral amine antiport. [3H]Dihydrotetrabenazine ([3H]TBZOH) is bound by chromaffin granule membranes on one class of site (T sites, KD = 3 nM); [3H]reserpine is bound on T sites and a second class of site (R1 sites, KD = 0.7 nM). The two sites are involved in monoamine translocation. The substrates displace the ligands with different efficiency: noradrenaline (Km = 10 microM) displaces reserpine efficiently (EC50 = 30 microM), but TBZOH poorly (EC50 = 2000 microM); m-iodobenzylguanidine, which has recently been shown to be a substrate of the monoamine uptake system (Km = 5 microM), displaces TBZOH efficiently (EC50 = 25 microM), but reserpine inefficiently (EC50 = 300 microM). Since both substrates are translocated by the same transporter, this result confirms the existence of two sites with different properties. T sites are characterized by a linear relationship between the reciprocal of the dissociation constants of various drugs displacing [3H]TBZOH and their partition coefficient in octanol/H2O mixtures. This relationship, which indicates a hydrophobic environment of T sites, does not exist for R1 sites. T sites have been identified by covalent labeling with a derivative of TBZ coupled to an arylazido group. The labeled sites are borne by a 65,000 dalton protein. The kinetics of reserpine binding are accelerated in the presence of ATP.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

丁苯那嗪(TBZ)和利血平是嗜铬颗粒膜儿茶酚胺摄取系统的两种抑制剂。它们是底物多巴胺和血清素的结构类似物,抑制单胺转运体,该转运体催化H⁺/中性胺反向转运。[³H]二氢丁苯那嗪([³H]TBZOH)在一类位点(T位点,KD = 3 nM)与嗜铬颗粒膜结合;[³H]利血平在T位点和另一类位点(R1位点,KD = 0.7 nM)结合。这两个位点参与单胺转运。底物以不同效率取代配体:去甲肾上腺素(Km = 10 μM)能有效取代利血平(EC50 = 30 μM),但对TBZOH的取代效果较差(EC50 = 2000 μM);间碘苄胍最近被证明是单胺摄取系统的底物(Km = 5 μM),能有效取代TBZOH(EC50 = 25 μM),但对利血平的取代效率较低(EC50 = 300 μM)。由于两种底物都由同一转运体转运,这一结果证实了存在两个性质不同的位点。T位点的特征是,各种取代[³H]TBZOH的药物解离常数的倒数与其在辛醇/水混合物中的分配系数之间存在线性关系。这种表明T位点存在疏水环境的关系在R1位点不存在。T位点已通过与偶联芳基叠氮基团的TBZ衍生物进行共价标记得以鉴定。标记位点由一种65000道尔顿的蛋白质携带。在ATP存在下,利血平结合的动力学加快。(摘要截短于250词)

相似文献

7
Dicyclohexylcarbodiimide inhibits the monoamine carrier of bovine chromaffin granule membrane.
Biochemistry. 1985 Feb 26;24(5):1239-44. doi: 10.1021/bi00326a028.

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验